Anti-CA19-9 / Sialyl Lewisa Antibody BHA10207319

Mfr.No.	MSM1X-25-P1ABX
Alternative Names	CA19.9 ; Ovarian tumor antigen ; Pancreatic tumor antigen ; Sialyl Lewis a
Antigen	CA19-9 / Sialyl Lewisa
Categories	Primary Antibodies
Cellular Localization	Cytoplasmic
Clonality	Monoclonal
Conjugate	Unconjugated
Description	CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is superb for staining of formalin-fixed, paraffin-embedded tissues.
Host	Mouse
Immunogen	Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Positive Control	Stomach
Reactivity	Human
Recombinant	FALSE
Regulatory	RUO

Swissprot	Not Applicable
Uniprot	Not Applicable
Gene Id	Not Applicable

Buffer	200μg/ml of Ab purified from Bioreactor Concentrate. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA at 1.0mg/ml.
Concentration	1.0mg/ml
Description	There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity	Purified Ab WITHOUT BSA at 1.0mg/ml

Applications

FACS, IF, IHC-F

Description

(No special pretreatment is required for the immunohistochemical staining of formalin-fixed, paraffin-embedded tissues) Optimal dilution for a specific application should be determined., FACS ; IF ; IHC-F

Dilution

FACS	0.5-1μg/million cells in 0.1ml
IF	0.5-1μg/ml
IHC-F	0.5-1.0μg/ml for 30 minutes at RT

Have you used this product?

Rate it now..!!

SKU	Supplier No.	Size	Your price	Quantity
BHA10207319	MSM1X-25-P1ABX	100µg	$393.20		Add to Cart

Anti-CA19-9 / Sialyl Lewisa Antibody BHA10207319

Contact us to order

Tel

Email

Contact us to order

Tel

Email

Reviews of Anti-CA19-9 / Sialyl Lewisa Antibody BHA10207319

Rate it now..!!